Vishy Iyer, professor of molecular genetics and microbiology, and Matt Cowperthwaite, research director of the NeuroTexas
Institute at St. David’s. Photo: Alex Wang

When patients are diagnosed with glioblastoma, one of the worst forms of brain cancer, their options are limited.

Even after surgically accessing the brain to remove as much of the tumor as possible and applying intense chemotherapy, the prognosis is poor. The average survival time is about 14 months.

“There are really no good treatments,” said Vishy Iyer, a professor of molecular genetics and microbiology in the College of Natural Sciences at The University of Texas at Austin, who is trying to change that.

“You can do surgery and chemotherapy, but glioblastoma is just bad to have.”

Continue reading…


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s